Clinical Trial Update: Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer? [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating clarithromycin for cancer cachexia in lung cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Lung Cancer

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: University of Nottingham | Conditions: Cachexia, Lung Cancer | Phase 2 | Status: TERMINATED